Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

04. Dezember 2025 13:00 ET | Quelle: DelveInsight Business Research LLP

Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight

New York, USA, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight Acute...
03. Dezember 2025 13:00 ET | Quelle: DelveInsight Business Research LLP

Sickle Cell Disease Market is Predicted to Exhibit Remarkable Growth at a CAGR of 22.1% During the Forecast Period (2025–2034) Across 6MM, Owing to the Increasing Prevalence, Awareness, and Advancements in Gene Therapies | DelveInsight

New York, USA, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Sickle Cell Disease Market is Predicted to Exhibit Remarkable Growth at a CAGR of 22.1% During the Forecast Period (2025–2034) Across 6MM, Owing to...
02. Dezember 2025 13:00 ET | Quelle: DelveInsight Business Research LLP

Migraine Clinical Trial Pipeline Expands as 30+ Companies Driving Innovation in Oncology Therapeutics Space | DelveInsight

New York, USA, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Migraine Clinical Trial Pipeline Expands as 30+ Companies Driving Innovation in Oncology Therapeutics Space | DelveInsight The migraine therapeutics...
01. Dezember 2025 13:00 ET | Quelle: DelveInsight Business Research LLP

Geographic Atrophy Market to Surge Significantly During the Forecast Period (2025–2034) Due to Rising Adoption of Complement Inhibitor Therapies | DelveInsight

New York, USA, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Geographic Atrophy Market to Surge Significantly During the Forecast Period (2025–2034) Due to Rising Adoption of Complement Inhibitor Therapies |...
27. November 2025 13:00 ET | Quelle: DelveInsight Business Research LLP

HER2-positive Gastric Cancer Clinical Trial Pipeline: Insights into a Growing Landscape with 20+ Companies Advancing Novel Treatments| DelveInsight

New York, USA, Nov. 27, 2025 (GLOBE NEWSWIRE) -- HER2-positive Gastric Cancer Clinical Trial Pipeline: Insights into a Growing Landscape with 20+ Companies Advancing Novel Treatments| DelveInsight ...
26. November 2025 13:00 ET | Quelle: DelveInsight Business Research LLP

Chemotherapy-induced Peripheral Neuropathy Treatment Market Poised for Strong Growth Throughout the Forecast Period (2025–2034) Amid Rising Chemotherapy Adoption | DelveInsight

New York, USA, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Chemotherapy-induced Peripheral Neuropathy Treatment Market Poised for Strong Growth Throughout the Forecast Period (2025–2034) Amid Rising...
25. November 2025 13:00 ET | Quelle: DelveInsight Business Research LLP

Chronic Heart Failure Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight

New York, USA, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Chronic Heart Failure Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight Chronic heart failure...
24. November 2025 13:00 ET | Quelle: DelveInsight Business Research LLP

Chronic Refractory Cough Market is Expected to Boom by 2034 Driven by Advancements in Treatment Options | DelveInsight

New York, USA, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Chronic Refractory Cough Market is Expected to Boom by 2034 Driven by Advancements in Treatment Options | DelveInsight The chronic refractory cough...
20. November 2025 13:00 ET | Quelle: DelveInsight Business Research LLP

Global Wound Healing Devices Market Poised for Robust Growth at a CAGR of ~5% by 2032, Driven by Rising Chronic Wound Burden | DelveInsight

New York, USA, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Global Wound Healing Devices Market Poised for Robust Growth at a CAGR of ~5% by 2032, Driven by Rising Chronic Wound Burden | DelveInsight The...
19. November 2025 13:00 ET | Quelle: DelveInsight Business Research LLP

Gene Therapy for Ocular Rare Disease Market to Exhibit Phenomenal Growth During the Forecast Period (2025–2034) Due to Expanding Pipeline and Clinical Trial Activities | DelveInsight

New York, USA, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Gene Therapy for Ocular Rare Disease Market to Exhibit Phenomenal Growth During the Forecast Period (2025–2034) Due to Expanding Pipeline and...

Nächste Seite